symbol |
SOLY |
会社名 | Soliton Inc (ソリトン) |
分野(sector) |
|
産業(industry) |
|
業種 |
先端医療機器 & テクノロジー
医療関連(Health Care)
|
概要 |
Soliton Inc is an aesthetic medical device company. The Company develops a Rapid Acoustic Pulse (RAP) device that works in partnership with a short pulse laser for tattoo removal. The RAP device in coordination with the pulsed laser removes ink pigment from the macrophages. The device also enables multiple passes in a single treatment that makes tattoo removal possible in two to three laser treatments. The RAP device uses an acoustic wave technology that creates audio waves and provides electronic wave shaping to reduce frequencies that cause heat and pain. The device also provides a reflector that eliminates cavitations and focused waves. ソリトンは米国の初期段階の医療機器メーカー。入れ墨除去のための音響衝撃波(RAP)装置の開発、商品化に注力する。従来のQスイッチレーザーによる除去技術と同社独自のRAP技術を組み合わせて使用し、劇的な治療期間の短縮化、および治療による副作用と費用の軽減の実現を目指す。本社所在地はテキサス州ヒューストン。
|
本社所在地 | 5304 Ashbrook Drive Houston TX 77081 USA |
代表者氏名 | -- - |
代表者役職名 | -- - |
電話番号 | +1 713-305-5041 |
設立年月日 | 40969 |
市場名 | NASDAQ Small Cap |
ipoyear | 年 |
従業員数 | -人 |
url | :www.soliton.com |
nasdaq_url | |
adr_tso | |
EBITDA | |
終値(lastsale) | |
時価総額(marketcap) | |
時価総額 | |
売上高 | |
企業価値(EV) | |
当期純利益 | |
決算概要 | BRIEF: For the three months ended 31 March 2019 Soliton Inc revenues was not reported. Net loss applicable to common stockholders increased from $1.7M to $3.4M. Higher net loss reflects General and administrative increase from $449K to $1.9M (expense) Interest Expense increase from $167K to $823K (expense) Sales and Marketing increase from $13K to $57K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.92 to -$0.43. |